On January 7,2023, the 30th Anniversary Conference of the Hepatology Branch of the Chinese Medical Association and the 2022 Annual Academic Conference of the Hepatology Branch of the Chinese Medical Association were officially opened. The authoritative experts from the domestic and foreign hepatology circles gathered in the beautiful coastal city of Xiamen and the online platform to share the cutting-edge academic developments and research hotspots in the field of liver disease. Professor Xu Xiaoyuan, chairman of the General Assembly and chairman of the Hepatology Branch, said that recalling the past 30 years, under the leadership of successive chairmen such as Professor Wang Baoen, Zhuang Hui, Jia Jidong, Wei Lai, and Duan Zhongping, all members of the Hepatology Branch continued to work hard and grew stronger. Professor Nan Yuemin, the co-chairman of the conference and the president-designate of the Hepatology Credit Committee, delivered a speech, thanking the Chinese Medical Association, the China Liver Health, the China Hepatitis Prevention and Treatment Foundation, as well as the experts from all over the country for their full support, and working together to promote the benefit of Chinese patients with liver diseases.
On January 6, on the eve of the opening of the annual meeting of the Chinese Academy of Hepatology, the China Liver Health held a "liver health promotion" conference, where experts from academic, public welfare and grass-roots medical and health institutions gathered to exchange views on China's plans, models and progress in promoting the elimination of the threat of viral hepatitis and related diseases. Zhuang Hui, professor of the Medical Department of Peking University and honorary chairman of the China Liver Health, and other experts made a report. Professor Wei Lai, the vice president of Tsinghua Changgeng Hospital and the China Liver Health, made a summary of the conference. Huang Yuan, Xu Xiaoyuan, Rong Yihui, Nan Yuemin, Zheng Sujun, You Hong, Li Jie, Yang Ming, Dang Shuangsuo, Shen Yingsheng, Li Jie, Feng Bo, Rao Huiying, Xu Jinghang and other academic experts and institutional heads presided over the relevant links of the meeting.
Academician Zhuang Hui's opening report explains the burden of liver disease in China Build domestic and international academic exchange platform
China Liver Health is an AAA-level national social organization approved by the Ministry of Civil Affairs of the People's Republic of China and in charge of it, with independent legal status. The expert group of China Liver Health, as a national liver health think tank connecting well-known domestic liver disease experts and academic backbones, will, under the guidance of the National Health and Health Commission, the National Bureau for Disease Control and Prevention, and the Ministry of Civil Affairs of the People's Republic of China, carry out in-depth cooperation with the China Center for Disease Control, disease control, medical and health institutions at all levels nationwide, promote domestic and international academic exchanges, carry out research cooperation in the fields of medical testing, and advocate the implementation of social public services, Improve the liver health level in China. Professor Nan Yuemin, Professor Wei Lai and Professor Xu Xiaoyuan jointly served as the group leader of the expert group, Professor Rao Huiying served as the secretary general, and Academician Zhuang Hui served as the general consultant. The total number of experts was 66.
List of all members of the expert group of China Liver Health
Group photo of some members of the expert group of China Liver Health The expert group warmly welcomes foreign scholars to join and cooperate, and is committed to building an international academic exchange platform for liver disease, serving the global health cause, and helping the World Health Organization to eliminate the harm of viral hepatitis by 2030. Zhuang Hui, academician of Peking University Medical Department, interpreted the burden of hepatitis disease in China. Wang Yu, chairman of the China Hepatitis Prevention and Control Foundation, introduced the implementation conditions of the whole-course management of viral hepatitis and related diseases. Dr. Chen Zhongdan, the representative office of the World Health Organization in China, interpreted the strategy of viral hepatitis in the global health sector from 2022 to 2030. Liu Zhongfu, a researcher at the AIDS Prevention Center of the China Center for Disease Control and Prevention, interpreted China's liver disease prevention and treatment policy.
Video: Dr. John Ward, chairman of the Global Hepatitis Elimination Alliance, introduces the current situation of eliminating hepatitis B and hepatitis C globally and in Asia. Director Li Mingyang introduced the situation of the China Liver Health, as a national social organization, which has actively offered suggestions to the government, served the academic industry, and accurately carried out academic exchanges and public welfare activities on liver disease in recent years. At the question discussion session hosted by Professor Feng Bo and Professor Rao Huiying of the People's Hospital of Peking University, Professor Xie Wen, Professor Shang Jia, Professor Huang Yan, Professor Rong Yihui and other on-site experts participated in the exchange. |
关注官方微信 
